BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

617 related articles for article (PubMed ID: 19028511)

  • 1. Implications of gene-drug interactions in smoking cessation for improving the prevention of chronic degenerative diseases.
    Quaak M; van Schayck CP; Knaapen AM; van Schooten FJ
    Mutat Res; 2009 Jul; 667(1-2):44-57. PubMed ID: 19028511
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Genetic variation in mu-opioid-receptor-interacting proteins and smoking cessation in a nicotine replacement therapy trial.
    Ray R; Jepson C; Wileyto EP; Dahl JP; Patterson F; Rukstalis M; Pinto A; Berrettini W; Lerman C
    Nicotine Tob Res; 2007 Nov; 9(11):1237-41. PubMed ID: 17978999
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Smoking cessation interventions in clinical practice.
    Cornuz J
    Eur J Vasc Endovasc Surg; 2007 Oct; 34(4):397-404. PubMed ID: 17681834
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Role of functional genetic variation in the dopamine D2 receptor (DRD2) in response to bupropion and nicotine replacement therapy for tobacco dependence: results of two randomized clinical trials.
    Lerman C; Jepson C; Wileyto EP; Epstein LH; Rukstalis M; Patterson F; Kaufmann V; Restine S; Hawk L; Niaura R; Berrettini W
    Neuropsychopharmacology; 2006 Jan; 31(1):231-42. PubMed ID: 16123753
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The pharmacology underlying pharmacotherapy for tobacco dependence: a focus on bupropion.
    Balfour DJ
    Int J Clin Pract; 2001; 55(1):53-7. PubMed ID: 11219320
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A randomized trial of nicotine replacement therapy in combination with reduced-nicotine cigarettes for smoking cessation.
    Becker KM; Rose JE; Albino AP
    Nicotine Tob Res; 2008 Jul; 10(7):1139-48. PubMed ID: 18629723
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Role of nicotine pharmacokinetics in nicotine addiction and nicotine replacement therapy: a review.
    Le Houezec J
    Int J Tuberc Lung Dis; 2003 Sep; 7(9):811-9. PubMed ID: 12971663
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Adverse effects of pharmacological therapy for nicotine addiction in smokers following a smoking cessation program.
    Barrueco M; Otero MJ; Palomo L; Jiménez-Ruiz C; Torrecilla M; Romero P; Riesco JA
    Nicotine Tob Res; 2005 Jun; 7(3):335-42. PubMed ID: 16085501
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Genetic variation as a predictor of smoking cessation success. A promising preventive and intervention tool for chronic respiratory diseases?
    Quaak M; van Schayck CP; Knaapen AM; van Schooten FJ
    Eur Respir J; 2009 Mar; 33(3):468-80. PubMed ID: 19251795
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Catechol-O-methyltransferase (COMT) gene variants predict response to bupropion therapy for tobacco dependence.
    Berrettini WH; Wileyto EP; Epstein L; Restine S; Hawk L; Shields P; Niaura R; Lerman C
    Biol Psychiatry; 2007 Jan; 61(1):111-8. PubMed ID: 16876132
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Association of the mu-opioid receptor gene with smoking cessation.
    Munafò MR; Elliot KM; Murphy MF; Walton RT; Johnstone EC
    Pharmacogenomics J; 2007 Oct; 7(5):353-61. PubMed ID: 17224915
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Nicotine preparations and other preparations for smoking cessation].
    Tonstad S
    Tidsskr Nor Laegeforen; 1999 Apr; 119(9):1289-93. PubMed ID: 10327851
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Pharmacotherapy of smoking cessation with application of nicotine and nicotine free drugs].
    Florek E; Piekoszewski W
    Przegl Lek; 2008; 65(10):700-5. PubMed ID: 19189582
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Smoking cessation treatment in a real-life setting: the Greek experience.
    Rovina N; Nikoloutsou I; Dima E; Michailidou M; Roussos C; Gratziou C
    Ther Adv Respir Dis; 2007 Dec; 1(2):93-104. PubMed ID: 19124351
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Pharmacogenetics in the treatment of tobacco addiction].
    Quaak M; van Schooten FJ; van Schayck CP
    Tijdschr Psychiatr; 2013; 55(11):891-8. PubMed ID: 24242150
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Bupropion for the treatment of nicotine withdrawal and craving.
    Mooney ME; Sofuoglu M
    Expert Rev Neurother; 2006 Jul; 6(7):965-81. PubMed ID: 16831112
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Controlled randomized trials of pharmaceutic aids for smoking cessation. Results and perspectives].
    Said S; Berlin I; Puech AJ
    Therapie; 1994; 49(4):313-9. PubMed ID: 7878597
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Are nicotine replacement strategies to facilitate smoking cessation safe?
    Lavelle C; Birek C; Scott DA
    J Can Dent Assoc; 2003 Oct; 69(9):592-7. PubMed ID: 14653935
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Association between 5-hydroxytryptamine transporter gene-linked polymorphic region and smoking behavior in Chinese males.
    Chu SL; Xiao D; Wang C; Jing H
    Chin Med J (Engl); 2009 Jun; 122(12):1365-8. PubMed ID: 19567154
    [TBL] [Abstract][Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 31.